Year: 2024
Type: article
Study design: Clinical Trial
Abstract: Toassess the effect of topical travoprost on subfoveal Choroidal Thickness in Primary open glaucoma patients. The choroidal thickness, a sign of ocular blood flow can be altered by prostaglandin analogues. Hence this study was done to analyse the choroidal thickness after travoprost therapy. : This Prospective, interventional study included 41 eyes of treatment naive POAG patients. Subfoveal choroidal thickness was measured at first visit and after 3 months of topical travoprost therapy by Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT). The measurements were compared before starting the treatment and after 3 months of treatment with travoprost therapy. The mean choroidal thickness pre-treatment was 296.73 ± 28.07 mm post treatment was 311.56 ± 33.38 µm. The mean difference in choroidal thickness between pre-treatment and post-treatment was found to be 14.8 ±15.1 µm with median value(IQR) of 8 (3 - 30) µm (p-value< 0.00) which was statistically significant. Thecurrent study showed that Subfoveal choroidal thickness(SFCT) changes with travoprost therapy.
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4402964384